Live Breaking News & Updates on Vivo Opportunity

Stay updated with breaking news from Vivo opportunity. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Soleno Therapeutics (NASDAQ:SLNO) Trading Up 3.1%

Shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO – Get Free Report) were up 3.1% during trading on Wednesday . The company traded as high as $42.04 and last traded at $42.04. Approximately 65,481 shares traded hands during mid-day trading, a decline of 82% from the average daily volume of 360,998 shares. The stock had previously closed […] ....

Robertw Baird , Bhatnagar Anish , Piper Sandler , Maven Securities , Vivo Capital , Securities Exchange Commission , York Mellon Corp , Vivo Opportunity Llc , Soleno Therapeutics Inc , Silverarc Capital Management , Soleno Therapeutics , Get Free Report , Vivo Opportunity , Exchange Commission , New York Mellon Corp , Capital Management , Diazoxide Choline Extended Release , Soleno Therapeutics Daily ,

Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Receives $14.94 Consensus PT from Brokerages

Terns Pharmaceuticals, Inc. (NASDAQ:TERN – Get Free Report) has earned a consensus rating of “Moderate Buy” from the eight brokerages that are covering the stock, Marketbeat reports. Two equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. The average 12 month price objective […] ....

Affinity Asset Advisors , Terns Pharmaceuticals , Terns Pharmaceuticals Price Performance , Analyst Recommendations For Terns Pharmaceuticals , Terns Pharmaceuticals Company Profile , Vivo Opportunity Llc , News Ratings For Terns Pharmaceuticals Daily , Insider Activity At Terns Pharmaceuticals , Terns Pharmaceuticals Inc , Get Free Report , Vivo Opportunity , Fire Capital , Asset Advisors , Get Free , Terns Pharmaceuticals Daily ,

Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Receives Average Rating of "Moderate Buy" from Analysts

Shares of Terns Pharmaceuticals, Inc. (NASDAQ:TERN – Get Free Report) have earned an average rating of “Moderate Buy” from the eight research firms that are currently covering the company, Marketbeat reports. Two investment analysts have rated the stock with a hold recommendation and six have assigned a buy recommendation to the company. The average twelve-month […] ....

Vivo Opportunity Llc , Terns Pharmaceuticals Inc , Affinity Asset Advisors , Terns Pharmaceuticals Stock Performance , News Ratings For Terns Pharmaceuticals Daily , Analyst Recommendations For Terns Pharmaceuticals , Terns Pharmaceuticals , Insider Transactions At Terns Pharmaceuticals , Get Free Report , Vivo Opportunity , Fire Capital , Asset Advisors , Get Free , Terns Pharmaceuticals Daily ,